HOME > Investors > Press Releases
2007-01-19
Korean FDA approves Phase I/II clinical trial for VM106
2007-01-19
US FDA approves Phase I clinical trial for VM202
2007-01-19
Korean FDA approves Phase I clinical trial for VM202
2007-01-19
VM initiates joint research effort with UCSF
2007-01-19
ViroMed acquires Genebiotech
11 12 13 14 15 16 17 18 19